1 - 25 of 38 results for author:"Sassa S." in Literature citations
Results Customize
› Repeat search in UniProtKB (13)
| Hypoxia decreases the expression of the two enzymes responsible for producing linear and cyclic tetrapyrroles in the heme biosynthetic pathway. Vargas P.D., Furuyama K., Sassa S., Shibahara S. FEBS J. 275:5947-5959(2008) · Mapped (3) |
| Dual gene defects involving delta-aminolaevulinate dehydratase and coproporphyrinogen oxidase in a porphyria patient. Akagi R., Inoue R., Muranaka S., Tahara T., Taketani S., Anderson K.E., Phillips J.D., Sassa S. Br. J. Haematol. 132:237-243(2006) · UniProtKB (2) |
| Differential gene expression profiling between wild-type and ALAS2-null erythroblasts: identification of novel heme-regulated genes. Fujiwara T., Harigae H., Takahashi S., Furuyama K., Nakajima O., Sun J., Igarashi K., Yamamoto M., Sassa S., Kaku M. et al. Biochem. Biophys. Res. Commun. 340:105-110(2006) · Mapped (6) |
| Identification of a human heme exporter that is essential for erythropoiesis. Quigley J.G., Yang Z., Worthington M.T., Phillips J.D., Sabo K.M., Sabath D.E., Berg C.L., Sassa S., Wood B.L., Abkowitz J.L. Cell 118:757-766(2004) · UniProtKB (1) |
| Marked developmental changes in heme oxygenase-1 (HO-1) expression in the mouse placenta: correlation between HO-1 expression and placental development. Watanabe S., Akagi R., Mori M., Tsuchiya T., Sassa S. Placenta 25:387-395(2004) · Mapped (16) |
| Protective role of heme oxygenase-1 in the intestinal tissue injury in an experimental model of sepsis. Fujii H., Takahashi T., Nakahira K., Uehara K., Shimizu H., Matsumi M., Morita K., Hirakawa M., Akagi R., Sassa S. Crit. Care Med. 31:893-902(2003) · Mapped (3) |
| CYP2E1 overexpression up-regulates both non-specific delta-aminolevulinate synthase and heme oxygenase-1 in the human hepatoma cell line HLE/2E1. Takahashi S., Takahashi T., Mizobuchi S., Matsumi M., Yokoyama M., Morita K., Miyazaki M., Namba M., Akagi R., Sassa S. Int. J. Mol. Med. 11:57-62(2003) · Mapped (15) |
| Aberrant iron accumulation and oxidized status of erythroid-specific delta-aminolevulinate synthase (ALAS2)-deficient definitive erythroblasts. Harigae H., Nakajima O., Suwabe N., Yokoyama H., Furuyama K., Sasaki T., Kaku M., Yamamoto M., Sassa S. Blood 101:1188-1193(2003) · Mapped (6) |
| A novel MPL point mutation resulting in thrombopoietin-independent activation. Abe M., Suzuki K., Inagaki O., Sassa S., Shikama H. Leukemia 16:1500-1506(2002) · Mapped (3) |
| Multiple mechanisms for hereditary sideroblastic anemia. Furuyama K., Sassa S. Cell. Mol. Biol. (Noisy-le-grand) 48:5-10(2002) · Mapped (4) |
| Splenomegaly induced by recombinant human granulocyte-colony stimulating factor in rats. Nakayama T., Kudo H., Suzuki S., Sassa S., Mano Y., Sakamoto S. Life Sci. 69:1521-1529(2001) · Mapped (1) |
| Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. Ogawa K., Sun J., Taketani S., Nakajima O., Nishitani C., Sassa S., Hayashi N., Yamamoto M., Shibahara S., Fujita H. et al. EMBO J. 20:2835-2843(2001) · Mapped (4) |
| Novel molecular defects of the delta-aminolevulinate dehydratase gene in a patient with inherited acute hepatic porphyria. Akagi R., Shimizu R., Furuyama K., Doss M.O., Sassa S. Hepatology 31:704-708(2000) · UniProtKB (1) |
| A novel mutation of the erythroid-specific gamma-aminolevulinate synthase gene in a patient with non-inherited pyridoxine-responsive sideroblastic anemia. Harigae H., Furuyama K., Kudo K., Hayashi N., Yamamoto M., Sassa S., Sasaki T. Am. J. Hematol. 62:112-114(1999) · UniProtKB (1) |
| Heme deficiency in erythroid lineage causes differentiation arrest and cytoplasmic iron overload. Nakajima O., Takahashi S., Harigae H., Furuyama K., Hayashi N., Sassa S., Yamamoto M. EMBO J. 18:6282-6289(1999) · Mapped (17) |
| A novel mutation of delta-aminolaevulinate dehydratase in a healthy child with 12% erythrocyte enzyme activity. Akagi R., Yasui Y., Harper P., Sassa S. Br. J. Haematol. 106:931-937(1999) · UniProtKB (1) |
| Three new mutations in the uroporphyrinogen decarboxylase gene in familial porphyria cutanea tarda. McManus J.F., Begley C.G., Sassa S., Ratnaike S. Hum. Mutat. 13:412-412(1999) · UniProtKB (1) |
| Effects of 5-fluorouracil derivative UFT on thymidylate synthetase and thymidine kinase in rat colorectal tumors. Sakamoto S., Kawachi Y., Iwama T., Kuwa K., Suzuki T., Mitamura T., Kudo H., Sassa S., Yoshimura S., Maemura T. et al. Anticancer Res. 19:245-250(1999) · Mapped (1) |
| R411C mutation of the ALAS2 gene encodes a pyridoxine-responsive enzyme with low activity. Furuyama K., Uno R., Urabe A., Hayashi N., Fujita H., Kondo M., Sassa S., Yamamoto M. Br. J. Haematol. 103:839-841(1998) · UniProtKB (1) |
| Positional cloning of the zebrafish sauternes gene: a model for congenital sideroblastic anaemia. Brownlie A., Donovan A., Pratt S.J., Paw B.H., Oates A.C., Brugnara C., Witkowska H.E., Sassa S., Zon L.I. |
| A zebrafish model for hepatoerythropoietic porphyria. Wang H., Long Q., Marty S.D., Sassa S., Lin S. |
| Additive effects of medroxyprogesterone acetate and 5-fluorouracil derivative on 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors. Sakamoto S., Hara Y., Mitamura T., Sassa S., Kudo H., Suzuki S., Kuwa K., Okayasu I., Shinoda H. Anticancer Drugs 9:351-357(1998) · Mapped (1) |
| Deficient heme and globin synthesis in embryonic stem cells lacking the erythroid-specific delta-aminolevulinate synthase gene. Harigae H., Suwabe N., Weinstock P.H., Nagai M., Fujita H., Yamamoto M., Sassa S. Blood 91:798-805(1998) · Mapped (6) |
| Preventive effects of polysaccharides extracted from human tubercle bacilli (specific substance of Maruyama) on colonic carcinogenesis in rats. Iida K., Fujita K., Hirai H., Goto H., Miyazaki S., Arai Y., Iwaki H., Otake M., Sassa S., Maemura M. et al. Cancer Detect. Prev. 21:476-482(1997) · Mapped (1) |
| Novel regulation of delta-aminolevulinate synthase in the rat harderian gland. Nagai M., Nagai T., Yamamoto M., Goto K., Bishop T.R., Hayashi N., Kondo H., Seyama Y., Kano K., Fujita H. et al. Biochem. Pharmacol. 53:643-650(1997) · Mapped (1) |